Amello Jason
- SEC CIK
- 0001451805
No open-market purchases or sales filed in the past year.
Current role at each company
- TCRX TScan Therapeutics, Inc.Chief Financial Officeras of Jan 22, 2026
- CADL Candel Therapeutics, Inc.Chief Financial Officeras of Nov 30, 2023
- ACER Acer Therapeutics Inc.Directoras of Mar 16, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Amello Jason as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CADL Candel Therapeutics, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2022 (view filing) | Dec 8-9 | 4 days | Amello JasonChief Financial Officer | PPurchase | +5.57K | $1.80 | +$10.0K | New position5.57K after | 2 lots |